EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype–Phenotype Correlations in Alport Syndrome—A Single-Center Experience

Ștefan Nicolaie Lujinschi, Bogdan Marian Sorohan, Bogdan Obrișcă, Alexandra Vrabie iD, Gabriela Lupușoru iD, Camelia Achim, Andreea Gabriella Andronesi iD, Andreea Covic, Gener Ismail

Genes · 2024

DOI: 10.3390/genes15050593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Ștefan Nicolaie Lujinschi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Collagen Type IV, Genetic Association Studies, Kidney Failure, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alport syndrome (AS) is a common and heterogeneous genetic kidney disease, that often leads to end-stage kidney disease (ESKD).

Methods

This is a single-center, retrospective study that included 36 adults with type IV collagen (COL4) mutations. Our main scope was to describe how genetic features influence renal survival.

Results

A total of 24 different mutations were identified, of which eight had not been previously described. Mutations affecting each of the type IV collagen α chains were equally prevalent (33.3%). Most of the patients had pathogenic variants (61.1%). Most patients had a family history of kidney disease (71%). The most prevalent clinical picture was nephritic syndrome (64%). One-third of the subjects had extrarenal manifestations, 41.6% of patients had ESKD at referral, and another 8.3% developed ESKD during follow-up. The median renal survival was 42 years (95% CI, 29.98–54.01). The COL4A4 group displayed better renal survival than the COL4A3 group (p = 0.027). Patients with missense variants had higher renal survival (p = 0.023). Hearing loss was associated with lower renal survival (p < 0.001).

Conclusions

Patients with COL4A4 variants and those with missense mutations had significantly better renal survival, whereas those with COL4A3 variants and those with hearing loss had worse prognoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryCollagen Type IVGenetic Association StudiesKidney Failure, ChronicHumansFemaleMaleAdultMiddle AgedMutationRetrospective StudiesAutoantigens

Stichwörter der Autor:innen

Alport syndromegenotype–phenotype correlationskidney survivalmonogenic kidney diseasestype IV collagen-related disorders

Substanzen

Collagen Type IVCOL4A4 protein, humantype IV collagen alpha3 chainAutoantigens

Autor:innen und Institutionen

  • Department of Nephrology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Department of Nephrology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
  • Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Nephrology Depatment, Dialysis and Renal Transplant Center, "Dr. C. I. Parhon" Clinical Hospital, 700503 Iasi, Romania.

ORCID-Profile: Alexandra Vrabie, Gabriela Lupușoru, Andreea Gabriella Andronesi

Zitieren

APA

Lujinschi, Ș. N., Sorohan, B. M., Obrișcă, B., Vrabie, A., Lupușoru, G., Achim, C., Andronesi, A. G., Covic, A., & Ismail, G. (2024). Genotype–Phenotype Correlations in Alport Syndrome—A Single-Center Experience. Genes. https://doi.org/10.3390/genes15050593

Vancouver

Lujinschi ȘN, Sorohan BM, Obrișcă B, Vrabie A, Lupușoru G, Achim C, et al. Genotype–Phenotype Correlations in Alport Syndrome—A Single-Center Experience. Genes. 2024. doi:10.3390/genes15050593

BibTeX
@article{Lujinschi2024,
  author = {Lujinschi, Ștefan Nicolaie and Sorohan, Bogdan Marian and Obrișcă, Bogdan and Vrabie, Alexandra and Lupușoru, Gabriela and Achim, Camelia and Andronesi, Andreea Gabriella and Covic, Andreea and Ismail, Gener},
  title = {Genotype–Phenotype Correlations in Alport Syndrome—A Single-Center Experience},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15050593}
}
Kostenlos starten →